[Imaging of soft tissue sarcomas: standard approaches and new strategies].
Soft tissue sarcomas are rare malignant neoplasms accounting for only 1% of malignant tumors in adults. Complete surgical resection of the tumor is key for therapeutic success. Comprehensive diagnostic imaging significantly contributes to adequate preoperative planning. With effective targeted molecular pharmacotherapies entering the clinical scenario, functional imaging strategies will have a significant effect on individual risk assessment and will contribute to optimized, noninvasive treatment response monitoring.
Berger
F
F
Institut für Klinische Radiologie, Klinikum der Universität München, Campus Grosshadern, Marchioninistrasse 15, Munich, Germany. Frank.Berger@med.uni-muenchen.de
Winkler
E C
EC
Ruderer
C
C
Reiser
M F
MF
D000328:Adult; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003952:Diagnostic Imaging; D018450:Disease Progression; D018572:Disease-Free Survival; D005121:Extremities / Q000473:pathology / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D009381:Neoplasms, Radiation-Induced / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D009389:Neovascularization, Pathologic / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012509:Sarcoma / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D012680:Sensitivity and Specificity; D012983:Soft Tissue Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery